Revenue has grown steadily to about $3.8 billion per quarter, but the combined ratio ranging from 86.3% to 99.4% and EPS swings of up to 51% suggest reserve-driven volatility warrants further investigation rather than a clear margin trend.
CNA Financial Corporation (CNA) annual income statement — 30-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Revenue | 15.08B | 14.71B | 14B | 13.13B | 11.89B | 11.55B | 10.69B | 10.77B | 10.13B | 9.54B | 9.37B | 9.1B | 9.69B | 9.93B | 9.36B | 8.95B | 9.21B | 8.47B | 7.8B | 9.88B | 10.38B | 9.86B | 9.92B | 11.71B | 12.29B | 13.1B | 15.41B | 16.29B | 17.09B | 17.2B | 16.99B |
| Revenue Growth % | 3.53% | 5.1% | 6.66% | 10.38% | 2.99% | 8.04% | -0.74% | 6.25% | 6.2% | 1.88% | 2.91% | -6.1% | -2.42% | 6.07% | 4.64% | -2.82% | 8.7% | 8.63% | -21.1% | -4.73% | 5.21% | -0.62% | -15.29% | -4.7% | -6.14% | -15% | -5.44% | -4.67% | -0.62% | 1.24% | 15.57% |
| Medical Costs & Claims | 10.01B | 10.19B | 9.54B | 8.71B | 8.14B | 7.81B | 7.58B | 7.19B | 6.91B | 6.54B | 6.52B | 6.92B | 6.91B | 7.17B | 7B | 6.67B | 4.99B | 5.29B | 5.72B | 7.53B | 7.58B | 8.54B | 8.13B | 11.88B | 10.18B | 13.19B | 11.71B | 14.04B | 13.9B | 13.65B | 13.56B |
| Medical Cost Ratio % | 66.37% | 69.27% | 68.12% | 66.38% | 68.48% | 67.68% | 70.93% | 66.77% | 68.16% | 68.57% | 69.59% | 76.08% | 71.28% | 72.17% | 74.79% | 74.48% | 54.13% | 62.44% | 73.38% | 76.17% | 73.06% | 86.62% | 81.87% | 101.42% | 82.84% | 100.69% | 76.01% | 86.19% | 81.3% | 79.37% | 79.84% |
| Gross Profit | 5.07B | 4.52B | 4.46B | 4.41B | 3.75B | 3.73B | 3.11B | 3.58B | 3.23B | 3B | 2.85B | 2.18B | 2.78B | 2.76B | 2.36B | 2.28B | 4.22B | 3.18B | 2.08B | 2.36B | 2.79B | 1.32B | 1.8B | -166M | 2.11B | -90M | 3.7B | 2.25B | 3.2B | 3.55B | 3.43B |
| Gross Margin % | 33.63% | 30.73% | 31.88% | 33.62% | 31.52% | 32.32% | 29.07% | 33.23% | 31.84% | 31.43% | 30.41% | 23.92% | 28.72% | 27.83% | 25.21% | 25.52% | 45.87% | 37.56% | 26.62% | 23.83% | 26.94% | 13.38% | 18.13% | -1.42% | 17.16% | -0.69% | 23.99% | 13.81% | 18.7% | 20.63% | 20.16% |
| Gross Profit Growth % | - | 1.3% | 1.13% | 17.74% | 0.43% | 20.12% | -13.16% | 10.88% | 7.6% | 5.3% | 30.82% | -21.8% | 0.72% | 17.07% | 3.37% | -45.93% | 32.75% | 53.28% | -11.88% | -15.71% | 111.74% | -26.63% | 1183.73% | -107.87% | 2444.44% | -102.43% | 64.24% | -29.57% | -9.92% | 3.58% | 148.61% |
| Operating Expenses | 3.69B | 2.9B | 3.25B | 2.9B | 2.93B | 2.27B | 2.29B | 2.35B | 2.26B | 1.69B | 1.71B | 1.63B | 1.58B | 1.49B | 1.5B | 1.41B | 3.11B | 2.64B | 2.64B | 1.13B | 1.15B | 1.16B | 1.29B | -11.75B | 1.76B | -12.78B | -11.51B | -13.76B | -13.43B | -13.45B | -13.36B |
| OpEx / Revenue % | 24.45% | 19.72% | 23.23% | 22.06% | 24.67% | 19.66% | 21.39% | 21.87% | 22.33% | 17.7% | 18.27% | 17.89% | 16.27% | 14.98% | 16.04% | 15.79% | 33.79% | 31.19% | 33.82% | 11.47% | 11.04% | 11.74% | 13.05% | -100.31% | 14.33% | -97.57% | -74.67% | -84.44% | -78.58% | -78.22% | -78.66% |
| Depreciation & Amortization | 75M | 70M | 67M | 73M | 51M | 54M | 60M | 68M | 79M | 88M | 77M | 84M | 83M | 101M | 125M | 79M | 78M | 86M | 78M | 64M | 48M | 54M | 75M | 7M | -45M | -115M | -133M | -35M | 51M | 88M | -14.3M |
| Combined Ratio % | 90.82% | 88.99% | 91.35% | 88.43% | 93.15% | 87.34% | 92.32% | 88.64% | 90.49% | 86.27% | 87.86% | 93.97% | 87.55% | 87.15% | 90.83% | 90.27% | 87.92% | 93.63% | 107.21% | 87.64% | 84.1% | 98.36% | 94.92% | 1.11% | 97.17% | 3.12% | 1.34% | 1.75% | 2.72% | 1.15% | 1.18% |
| Operating Income | 1.39B | 1.62B | 1.21B | 1.52B | 814M | 1.46B | 821M | 1.22B | 964M | 1.31B | 1.14B | 549M | 1.21B | 1.28B | 859M | 871M | 1.11B | 540M | -562M | 1.22B | 1.65B | 162M | 504M | 11.59B | 348M | 12.69B | 15.2B | 16.01B | 16.63B | 17B | 16.79B |
| Operating Margin % | 9.18% | 11.01% | 8.65% | 11.57% | 6.85% | 12.66% | 7.68% | 11.36% | 9.51% | 13.73% | 12.14% | 6.03% | 12.45% | 12.85% | 9.17% | 9.73% | 12.08% | 6.37% | -7.21% | 12.36% | 15.9% | 1.64% | 5.08% | 98.89% | 2.83% | 96.88% | 98.66% | 98.25% | 97.28% | 98.85% | 98.82% |
| Operating Income Growth % | - | 33.77% | -20.22% | 86.49% | -44.32% | 78.08% | -32.87% | 26.87% | -26.41% | 15.22% | 107.1% | -54.52% | -5.41% | 48.54% | -1.38% | -21.67% | 105.93% | 196.09% | -145.99% | -25.94% | 918.52% | -67.86% | -95.65% | 3229.02% | -97.26% | -16.53% | -5.04% | -3.72% | -2.19% | 1.27% | 1510.48% |
| EBITDA | 1.46B | 1.69B | 1.28B | 1.59B | 865M | 1.52B | 881M | 1.29B | 1.04B | 1.4B | 1.21B | 633M | 1.29B | 1.38B | 984M | 950M | 1.19B | 626M | -484M | 1.29B | 1.7B | 216M | 579M | 11.59B | 303M | 12.57B | 15.07B | 15.97B | 16.68B | 17.09B | 16.77B |
| EBITDA Margin % | 9.68% | 11.49% | 9.13% | 12.12% | 7.27% | 13.13% | 8.24% | 11.99% | 10.29% | 14.65% | 12.96% | 6.96% | 13.31% | 13.86% | 10.51% | 10.62% | 12.92% | 7.39% | -6.21% | 13.01% | 16.36% | 2.19% | 5.83% | 98.95% | 2.46% | 96.01% | 97.8% | 98.04% | 97.58% | 99.36% | 98.74% |
| Interest Expense | 134M | 135M | 133M | 127M | 112M | 113M | 122M | 131M | 138M | 161M | 159M | 155M | 183M | 166M | 170M | 175M | 157M | 128M | 134M | 140M | 131M | 124M | 124M | 130M | 150M | 157M | 206M | 202M | 219M | 198M | 200.4M |
| Non-Operating Income | -36M | -135M | -133M | -127M | -112M | -113M | -122M | -131M | -138M | -161M | -159M | -155M | -183M | -166M | -170M | -175M | -157M | -128M | -134M | -140M | -131M | -124M | -124M | 11.46B | -143M | 12.53B | 15B | 15.81B | 16.41B | 16.8B | 16.59B |
| Pretax Income | 1.29B | 1.62B | 1.21B | 1.52B | 814M | 1.46B | 821M | 1.22B | 964M | 1.31B | 1.14B | 549M | 1.21B | 1.28B | 859M | 871M | 1.11B | 540M | -562M | 1.22B | 1.65B | 162M | 504M | -2.33B | 341M | -2.29B | 1.73B | -87M | 275M | 1.36B | 1.34B |
| Pretax Margin % | 8.53% | 11.01% | 8.65% | 11.57% | 6.85% | 12.66% | 7.68% | 11.36% | 9.51% | 13.73% | 12.14% | 6.03% | 12.45% | 12.85% | 9.17% | 9.73% | 12.08% | 6.37% | -7.21% | 12.36% | 15.9% | 1.64% | 5.08% | -19.91% | 2.77% | -17.52% | 11.21% | -0.53% | 1.61% | 7.9% | 7.92% |
| Income Tax | -23M | 342M | 252M | 313M | 132M | 278M | 131M | 223M | 151M | 411M | 278M | 70M | 319M | 361M | 239M | 242M | 333M | 57M | -311M | 317M | 469M | -105M | 31M | -913M | 68M | -744M | 550M | -88M | 47M | 392M | 380.2M |
| Effective Tax Rate % | -1.79% | 21.11% | 20.81% | 20.62% | 16.22% | 19.02% | 15.96% | 18.23% | 15.66% | 31.37% | 24.45% | 12.75% | 26.43% | 28.29% | 27.82% | 27.78% | 29.95% | 10.56% | 55.34% | 25.94% | 28.42% | -64.81% | 6.15% | 39.15% | 19.94% | 32.43% | 31.85% | 101.15% | 17.09% | 28.87% | 28.27% |
| Net Income | 1.14B | 1.28B | 959M | 1.21B | 682M | 1.18B | 690M | 1B | 813M | 899M | 859M | 479M | 691M | 937M | 628M | 612M | 690M | 419M | -299M | 851M | 1.11B | 264M | 425M | -1.42B | 163M | -1.6B | 1.18B | -172M | 228M | 966M | 964.8M |
| Net Margin % | 7.57% | 8.69% | 6.85% | 9.18% | 5.74% | 10.25% | 6.46% | 9.29% | 8.02% | 9.42% | 9.17% | 5.26% | 7.13% | 9.43% | 6.71% | 6.84% | 7.49% | 4.95% | -3.83% | 8.61% | 10.68% | 2.68% | 4.28% | -12.1% | 1.33% | -12.25% | 7.67% | -1.06% | 1.33% | 5.62% | 5.68% |
| Net Income Growth % | 14.54% | 33.26% | -20.41% | 76.69% | -42.4% | 71.59% | -31% | 23% | -9.57% | 4.66% | 79.33% | -30.68% | -26.25% | 49.2% | 2.61% | -11.3% | 64.68% | 240.13% | -135.14% | -23.19% | 319.7% | -37.88% | 129.99% | -969.33% | 110.16% | -235.79% | 787.21% | -175.44% | -76.4% | 0.12% | 27.45% |
| EPS (Diluted) | 4.20 | 4.69 | 3.52 | 4.43 | 2.50 | 4.41 | 2.53 | 2.53 | 2.98 | 3.30 | 3.17 | 1.77 | 2.55 | 3.47 | 2.33 | 2.27 | 2.28 | 1.10 | -1.11 | 3.13 | 4.05 | 0.76 | 1.40 | -6.32 | 0.72 | -8.18 | 6.40 | -0.68 | 1.19 | 5.20 | 1.72 |
| EPS Growth % | 3.64% | 33.24% | -20.54% | 77.2% | -43.31% | 74.31% | 0% | -15.1% | -9.7% | 4.1% | 79.1% | -30.59% | -26.51% | 48.93% | 2.64% | -0.44% | 107.27% | 199.1% | -135.46% | -22.72% | 432.89% | -45.71% | 122.15% | -977.78% | 108.8% | -227.81% | 1041.18% | -157.14% | -77.12% | 202.33% | -57.53% |
| EPS (Basic) | - | 4.71 | 3.53 | 4.44 | 2.51 | 4.42 | 2.54 | 2.54 | 2.99 | 3.32 | 3.18 | 1.77 | 2.56 | 3.48 | 2.33 | 2.27 | 2.28 | 1.10 | -1.11 | 3.13 | 4.06 | 0.76 | 1.40 | -6.32 | 0.72 | -8.18 | 6.40 | -0.68 | 1.19 | 5.20 | 1.72 |
| Diluted Shares Outstanding | 272M | 272.3M | 272.7M | 272.2M | 272.5M | 272.8M | 272.8M | 272.4M | 272.5M | 272.1M | 271.1M | 270.7M | 270.6M | 270.2M | 269.8M | 269.6M | 269.5M | 269.1M | 269.4M | 271.8M | 262.3M | 256M | 256M | 226.88M | 226.39M | 200.88M | 184.53M | 190.11M | 185.71M | 185.65M | 185.59M |
Quick answers to the most common questions about buying CNA stock.
For fiscal year 2025, CNA Financial Corporation (CNA) reported total revenue of $14.71B. This represents a 13.4% decline compared to $16.99B in 1996.
CNA Financial Corporation (CNA) is profitable, generating $1.28B in net income for the fiscal year ending 2025 with a net profit margin of 8.7%.
CNA Financial Corporation (CNA) reported an operating income of $1.62B, resulting in an operating profit margin of 11.0%. This margin reflects the operational efficiency of the business before interest and taxes.
CNA Financial Corporation (CNA) generated $4.52B in gross profit for the year, representing a gross profit margin of 30.7%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Long-tail reserve adequacy
Metrics are mathematically derived from official filings.
Combined Ratio Volatility Masks Underlying Discipline
Based on CNA's reported quarterly figures, the combined ratio ranged from 86.3% to 99.4% over the last ten quarters, with the Q4 2024 spike to 99.4% suggesting a meaningful underwriting shortfall that warrants further investigation rather than a clear trend.
The reported loss ratios of 59.2% to 70.3% indicate that loss cost variability, rather than expense discipline, is driving most of the quarterly swings in underwriting profitability. Sustained combined ratios below 92% in most recent quarters suggest that rate increases are currently outpacing loss cost inflation, though a single quarter at 99.4% shows how quickly that margin can compress. Investors should monitor whether the 2026Q3 result of 93.0% signals a reversal of the favorable 2026Q1 and Q2 underwriting trend.
Q3 Earnings Miss Tied to LTC Reassessment
According to the reported Q3 2026 results, CNA's EPS of $0.75 fell short of the $1.08 consensus, with management attributing the shortfall to annual long-term care reserve assumption updates rather than core underwriting deterioration.
The gap between management's characterization of strong core income of $203 million and the consensus miss suggests that reserve reassessments in the Life and Group run-off segment are a material and potentially recurring driver of reported earnings. This pattern may indicate that the prior-quarter earnings strength was less durable than headline figures implied. Investors should track whether adverse development continues to appear in long-tail lines, as this would challenge the conservatism thesis underpinning CNA's reserve position.
Revenue Growth Steady but Earnings Volatile
Reported revenue growth of roughly 2% to 7% per quarter across the period indicates steady premium expansion, yet EPS swings of up to 51% quarter over quarter show that top-line stability is not translating into consistent bottom-line results.
Revenue growth in the 5% range is consistent with a firm operating within a firm commercial pricing environment, though the Q3 2026 slowdown to 1.9% may suggest moderating rate momentum. The divergence between revenue growth and net income implies that investment results and reserve movements are contributing more to earnings variability than premium volume. Analysts should weigh whether premium growth can be sustained without compromising underwriting margins.
Earnings Quality Questioned by Reserve Swings
The strongest challenge to CNA's reported earnings is that quarterly net income has moved between $21 million and $403 million, a range that may indicate reserve-driven noise obscuring the true run-rate of underwriting profitability.
If the Q4 2024 net income of $21 million and the Q3 2026 EPS miss reflect actuarial reassessments rather than operating conditions, then reported quarterly profitability may overstate the durability of current margins. Investment yield data is not available in the supplied figures, so the contribution of net investment income to total earnings cannot be verified. Investors should treat favorable quarters with caution until reserve development trends are clarified.